Lawson Research Institute

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1983-01-01

Employees: -

Market Cap: -

Website: http://www.lawsonresearch.ca

Clinical Trials

Prebiotics for Spinal Cord Injury Patients With Bowel and Bladder Dysfunction

Phase 3

Completed

Conditions: Neurogenic Bowel
Spinal Cord Injuries
Bladder Dysfunction

Interventions: Dietary Supplement: Human Milk Oligosaccharides (HMO)
Other: Placebo

First Posted Date: 2019-06-14

Last Posted Date: 2023-12-13

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 30

Registration Number: NCT03987126

Locations: 🇨🇦
Parkwood Institute, London, Ontario, Canada

CIrculating Tumour DNA in Lung Cancer (CITaDeL): Optimizing Sensitivity and Clinical Utility

Completed

Conditions: Lung Cancer
Non Small Cell Lung Cancer
Lung Neoplasms
Neoplasm of Lung

Interventions: Other: Circulating tumour DNA (ctDNA)

First Posted Date: 2019-06-14

Last Posted Date: 2021-02-18

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 40

Registration Number: NCT03986463

Locations: 🇨🇦
London Regional Cancer Program, London, Ontario, Canada

Comparing CBT-T to CBT-E in Non-low-weight Adults With Eating Disorders

Not Applicable

Conditions: Eating Disorders

Interventions: Behavioral: Cognitive Behavioural Therapy-Ten
Behavioral: Cognitive Behavioural Therapy-Enhanced

First Posted Date: 2019-06-13

Last Posted Date: 2022-05-20

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 60

Registration Number: NCT03984539

Locations: 🇨🇦
The Adult Eating Disorders Service, London, Ontario, Canada

Three Fraction Radiation to Induce Immuno-Oncologic Response

Not Applicable

Active, not recruiting

Conditions: Locally Advanced Breast Cancer
High-Risk Cancer

Interventions: Radiation: Neoadjuvant radiotherapy

First Posted Date: 2019-06-07

Last Posted Date: 2025-02-26

Lead Sponsor: London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's

Target Recruit Count: 40

Registration Number: NCT03978663

Locations: 🇨🇦
London Regional Cancer Program, London, Ontario, Canada

Advanced Therapeutics in Rheumatoid Arthritis (RA)

Phase 4

Recruiting

Conditions: Rheumatoid Arthritis

Interventions: Drug: tofacitinib
Drug: Etanercept

First Posted Date: 2019-06-05

Last Posted Date: 2024-11-28

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 144

Registration Number: NCT03976245

Locations: 🇨🇦
Rheumatology Clinic, St. Joseph's Health Care, London, Ontario, Canada

Intranasal Dexmedetomidine Dose-finding Study

Phase 2

Completed

Conditions: Laceration Repair

Interventions: Drug: Dexmedetomidine

First Posted Date: 2019-05-21

Last Posted Date: 2022-04-07

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 55

Registration Number: NCT03957304

Locations: 🇨🇦
London Health Sciences Centre, London, Ontario, Canada

The Parkwood Pacing and Planning™ App

Not Applicable

Recruiting

Conditions: Acquired Brain Injury

Interventions: Device: Pacing and Planning App

First Posted Date: 2019-05-21

Last Posted Date: 2023-03-24

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 200

Registration Number: NCT03957343

Locations: 🇨🇦
Parkwood Institute, London, Ontario, Canada

The Clinical Course of Interstitial Pneumonia With Autoimmune Features

Completed

Conditions: Interstitial Pneumonia

First Posted Date: 2019-05-15

Last Posted Date: 2025-03-10

Lead Sponsor: London Health Sciences Centre Research Institute and Lawson Research Institute of St. Joseph's

Target Recruit Count: 68

Registration Number: NCT03950583

Locations: 🇨🇦
London Health Science Centre, London, Ontario, Canada

Oakland-Jairath Score Validation

Completed

Conditions: Lower Gastrointestinal Bleeding

First Posted Date: 2019-05-02

Last Posted Date: 2024-03-22

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 344

Registration Number: NCT03935360

Locations: 🇨🇦
University of Alberta Hospital, Edmonton, Alberta, Canada
🇨🇦
McGill University Health Centre, Montreal, Quebec, Canada
🇨🇦
Health Science Centre, Winnipeg, Manitoba, Canada

and more 3 locations

Pleurodesis Using Hypertonic Glucose to Treat Post-operative Air Leaks

Phase 1

Completed

Conditions: Postoperative Air Leak

Interventions: Drug: 200 mL of 50% Glucose
Drug: 50 mL of 50% Glucose
Drug: 100 mL of 50% Glucose
Drug: 150 mL of 50% Glucose

First Posted Date: 2019-04-05

Last Posted Date: 2021-05-12

Lead Sponsor: Lawson Health Research Institute

Target Recruit Count: 12

Registration Number: NCT03905408

Locations: 🇨🇦
London Health Sciences Centre, London, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy